This infographic illustrates how the drug Senolytix-P3 inhibits the hyperactive NLRP3 Inflammasome in aging cells, reducing pro-inflammatory cytokine release and cellular senescence. Experimental data shows significant reductions in IL-1β and senescence markers, leading to an increased lifespan in treated models.